Review



rabbit anti agmat novus biological  (Novus Biologicals)


Bioz Verified Symbol Novus Biologicals is a verified supplier
Bioz Manufacturer Symbol Novus Biologicals manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    Novus Biologicals rabbit anti agmat novus biological
    Rabbit Anti Agmat Novus Biological, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti agmat novus biological/product/Novus Biologicals
    Average 91 stars, based on 1 article reviews
    rabbit anti agmat novus biological - by Bioz Stars, 2026-06
    91/100 stars

    Images



    Similar Products

    91
    Novus Biologicals rabbit anti agmat novus biological
    Rabbit Anti Agmat Novus Biological, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti agmat novus biological/product/Novus Biologicals
    Average 91 stars, based on 1 article reviews
    rabbit anti agmat novus biological - by Bioz Stars, 2026-06
    91/100 stars
      Buy from Supplier

    96
    Novus Biologicals rabbit anti agmat

    Rabbit Anti Agmat, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti agmat/product/Novus Biologicals
    Average 96 stars, based on 1 article reviews
    rabbit anti agmat - by Bioz Stars, 2026-06
    96/100 stars
      Buy from Supplier

    90
    Millipore rabbit anti-agmat ihc
    ARG1, <t>AGMAT,</t> arginine, and RBM39 in human HCC patients (A) Schematic representation of arginine and polyamine metabolism in HCC patients. Boxes below enzymes indicate changes in mRNA (left box) and protein (right box) levels in human HCC tumors (T) compared to paired non-tumor (NT) biopsies, respectively. Color coding according to level of log 2 fold-change as indicated. “?” indicates unknown identity. Tumor aggressiveness is indicated by Edmondson-Steiner grade low (Edm. low, grade I and II) and high (Edm. high, grade III and IV). n = 73 (Edm. low) and n = 49 (Edm. high) for mRNA; n = 30 (Edm. low) and n = 21 (Edm. high) for protein. (B) Immunoblots of ARG1, AGMAT, RBM39, and ASNS in paired non-tumor (NT) and tumor (T) tissues of five HCC patients. Calnexin serves as loading control. (C) Tissue microarray for ARG1 and AGMAT. ARG1, normal liver n = 58, HCC n = 160; AGMAT, normal liver n = 49, HCC n = 142. (D) <t>Representative</t> <t>IHC</t> of ARG1 and AGMAT of an HCC patient (from C). Non-tumor, NT; tumor, T. (E) Kaplan-Meier survival estimate curve for The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) patients ranked by expression of ARG1 and AGMAT . n = 89 (low), n = 109 (normal). (F) Urea cycle metabolites in tumors (T) relative to paired non-tumor (NT) liver tissues (log 2 ratio). n = 11. (G) Immunoblots of RBM39 in tumor lysate (Input) and elution after purification with leucine (Leu)- or arginine (Arg)-coupled agarose beads from three HCC patients. Calnexin serves as input and negative control. (H) Dose-response curve of 20 HCC patient-derived organoids treated with indisulam. Data are presented as the percentage of control DMSO-treated tumor organoids. (I) Model. In liver cancer cells, loss of ARG1 and AGMAT preserves arginine, which in turn binds RBM39 to promote metabolic reprogramming. Arginine-RBM39-mediated ASNS expression further enhances arginine uptake. Trsx, transcription. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired t test (C), log rank test (E), and multiple t test (F).
    Rabbit Anti Agmat Ihc, supplied by Millipore, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti-agmat ihc/product/Millipore
    Average 90 stars, based on 1 article reviews
    rabbit anti-agmat ihc - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    99
    Danaher Inc rabbit polyclonal antibody to agmat
    Endometrial expression of mRNAs for progestamedins, enzymes involved in polyamine synthesis, and nutrient transporters. Expression of FGF10 ( d ), AZIN2 (H), SLC6A9 ( q ), and SLC1A4 ( r ) were affected by treatment. Expression of SLC2A1 ( n ), SLC5A1 ( o ), and SLC7A1 ( p ) were affected by day. Expression of FGF10 ( b ), ODC1 ( e ), SLC2A1 ( i ), SLC5A1 ( j ), SLC7A1 ( k ), and SLC6A9 ( l ) were affected by a day × treatment interaction. Expression of FGF7 ( a ), HGF ( c ), AZIN2 ( f ) , and <t>AGMAT</t> ( g ) were not affected by a day × treatment interaction. There was a tendency for the endometrial expression of SLC1A4 ( m ) to be affected by a day × treatment interaction. Data are presented as LSM ± SEM. Different means are indicated by different letters. Only endometria from ewes which were considered pregnant with normally developed conceptuse were utilized for these analyses
    Rabbit Polyclonal Antibody To Agmat, supplied by Danaher Inc, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody to agmat/product/Danaher Inc
    Average 99 stars, based on 1 article reviews
    rabbit polyclonal antibody to agmat - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    97
    Cell Signaling Technology Inc rabbit anti agmat polyclonal igg
    Endometrial expression of mRNAs for progestamedins, enzymes involved in polyamine synthesis, and nutrient transporters. Expression of FGF10 ( d ), AZIN2 (H), SLC6A9 ( q ), and SLC1A4 ( r ) were affected by treatment. Expression of SLC2A1 ( n ), SLC5A1 ( o ), and SLC7A1 ( p ) were affected by day. Expression of FGF10 ( b ), ODC1 ( e ), SLC2A1 ( i ), SLC5A1 ( j ), SLC7A1 ( k ), and SLC6A9 ( l ) were affected by a day × treatment interaction. Expression of FGF7 ( a ), HGF ( c ), AZIN2 ( f ) , and <t>AGMAT</t> ( g ) were not affected by a day × treatment interaction. There was a tendency for the endometrial expression of SLC1A4 ( m ) to be affected by a day × treatment interaction. Data are presented as LSM ± SEM. Different means are indicated by different letters. Only endometria from ewes which were considered pregnant with normally developed conceptuse were utilized for these analyses
    Rabbit Anti Agmat Polyclonal Igg, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti agmat polyclonal igg/product/Cell Signaling Technology Inc
    Average 97 stars, based on 1 article reviews
    rabbit anti agmat polyclonal igg - by Bioz Stars, 2026-06
    97/100 stars
      Buy from Supplier

    Image Search Results


    Journal: Cell

    Article Title: Arginine reprograms metabolism in liver cancer via RBM39

    doi: 10.1016/j.cell.2023.09.011

    Figure Lengend Snippet:

    Article Snippet: Rabbit anti-AGMAT , Novus Biological , Cat#1-82080.

    Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, Luciferase, Reporter Assay, RNA Sequencing, Control, Mutagenesis, CRISPR, Plasmid Preparation, shRNA, Software

    ARG1, AGMAT, arginine, and RBM39 in human HCC patients (A) Schematic representation of arginine and polyamine metabolism in HCC patients. Boxes below enzymes indicate changes in mRNA (left box) and protein (right box) levels in human HCC tumors (T) compared to paired non-tumor (NT) biopsies, respectively. Color coding according to level of log 2 fold-change as indicated. “?” indicates unknown identity. Tumor aggressiveness is indicated by Edmondson-Steiner grade low (Edm. low, grade I and II) and high (Edm. high, grade III and IV). n = 73 (Edm. low) and n = 49 (Edm. high) for mRNA; n = 30 (Edm. low) and n = 21 (Edm. high) for protein. (B) Immunoblots of ARG1, AGMAT, RBM39, and ASNS in paired non-tumor (NT) and tumor (T) tissues of five HCC patients. Calnexin serves as loading control. (C) Tissue microarray for ARG1 and AGMAT. ARG1, normal liver n = 58, HCC n = 160; AGMAT, normal liver n = 49, HCC n = 142. (D) Representative IHC of ARG1 and AGMAT of an HCC patient (from C). Non-tumor, NT; tumor, T. (E) Kaplan-Meier survival estimate curve for The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) patients ranked by expression of ARG1 and AGMAT . n = 89 (low), n = 109 (normal). (F) Urea cycle metabolites in tumors (T) relative to paired non-tumor (NT) liver tissues (log 2 ratio). n = 11. (G) Immunoblots of RBM39 in tumor lysate (Input) and elution after purification with leucine (Leu)- or arginine (Arg)-coupled agarose beads from three HCC patients. Calnexin serves as input and negative control. (H) Dose-response curve of 20 HCC patient-derived organoids treated with indisulam. Data are presented as the percentage of control DMSO-treated tumor organoids. (I) Model. In liver cancer cells, loss of ARG1 and AGMAT preserves arginine, which in turn binds RBM39 to promote metabolic reprogramming. Arginine-RBM39-mediated ASNS expression further enhances arginine uptake. Trsx, transcription. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired t test (C), log rank test (E), and multiple t test (F).

    Journal: Cell

    Article Title: Arginine reprograms metabolism in liver cancer via RBM39

    doi: 10.1016/j.cell.2023.09.011

    Figure Lengend Snippet: ARG1, AGMAT, arginine, and RBM39 in human HCC patients (A) Schematic representation of arginine and polyamine metabolism in HCC patients. Boxes below enzymes indicate changes in mRNA (left box) and protein (right box) levels in human HCC tumors (T) compared to paired non-tumor (NT) biopsies, respectively. Color coding according to level of log 2 fold-change as indicated. “?” indicates unknown identity. Tumor aggressiveness is indicated by Edmondson-Steiner grade low (Edm. low, grade I and II) and high (Edm. high, grade III and IV). n = 73 (Edm. low) and n = 49 (Edm. high) for mRNA; n = 30 (Edm. low) and n = 21 (Edm. high) for protein. (B) Immunoblots of ARG1, AGMAT, RBM39, and ASNS in paired non-tumor (NT) and tumor (T) tissues of five HCC patients. Calnexin serves as loading control. (C) Tissue microarray for ARG1 and AGMAT. ARG1, normal liver n = 58, HCC n = 160; AGMAT, normal liver n = 49, HCC n = 142. (D) Representative IHC of ARG1 and AGMAT of an HCC patient (from C). Non-tumor, NT; tumor, T. (E) Kaplan-Meier survival estimate curve for The Cancer Genome Atlas Liver Hepatocellular Carcinoma (TCGA-LIHC) patients ranked by expression of ARG1 and AGMAT . n = 89 (low), n = 109 (normal). (F) Urea cycle metabolites in tumors (T) relative to paired non-tumor (NT) liver tissues (log 2 ratio). n = 11. (G) Immunoblots of RBM39 in tumor lysate (Input) and elution after purification with leucine (Leu)- or arginine (Arg)-coupled agarose beads from three HCC patients. Calnexin serves as input and negative control. (H) Dose-response curve of 20 HCC patient-derived organoids treated with indisulam. Data are presented as the percentage of control DMSO-treated tumor organoids. (I) Model. In liver cancer cells, loss of ARG1 and AGMAT preserves arginine, which in turn binds RBM39 to promote metabolic reprogramming. Arginine-RBM39-mediated ASNS expression further enhances arginine uptake. Trsx, transcription. ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗∗ p < 0.0001 by unpaired t test (C), log rank test (E), and multiple t test (F).

    Article Snippet: Rabbit anti-AGMAT (for IHC) , Sigma , Cat#PA5-55311.

    Techniques: Western Blot, Microarray, Expressing, Purification, Negative Control, Derivative Assay

    ARG1 and AGMAT are decreased and arginine, RBM39, and ASNS are increased in HCC patient tumors that are sensitive to RBM39 depletion by indisulam, related to <xref ref-type=Figure 7 (A) RBM39 mRNA levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio. n = 73 (Edm. low), n = 49 (Edm. high). (B) RBM39 protein levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio. n = 30 (Edm. low), n = 21 (Edm. high). (C) ASNS mRNA levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio. n = 73 (Edm. low), n = 49 (Edm. high). (D) ASNS protein levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio, if applicable. BW, black-and-white, i.e., only detected in tumor tissues. n = 3 (Edm. low), n = 8 (Edm. high). (E) Staging of ARG1 and AGMAT IHC staining in tissue micro array. (F) mRNA expression of ARG1 , AGMAT , RBM39 , and ASNS in early-stage HCC (data from Jiang et al. ). log 2 fold-change tumor (T) relative to non-tumor (NT) tissues. n = 35. (G) Kaplan-Meier survival estimate curve for TCGA-LIHC patients ranked by expression of ARG1 . n = 135 (low), n =155 (normal). (H) Kaplan-Meier survival estimate curve for TCGA-LIHC patients ranked by expression of AGMAT . n = 136 (low), n = 158 (normal). (I) Polyamine species in tumors (T) relative to paired non-tumor (NT) liver tissues (log 2 ratio). n = 11. (J) Arginine content in paired non-tumor (NT) and tumor (T) tissues of HCC patients. n = 10. (K) Total polyamine content in paired non-tumor (NT) and tumor (T) tissues of HCC patients. n = 10. (L) Volcano plot of the −log 10 (adjusted p value) against the log 2 fold-change of 600 proteins identified by MS (in minimum 2 out of 3 samples) after purification from HCC tissues by arginine (Arg)- compared to leucine (Leu)-coupled agarose beads. Red dot highlights RBM39. (M) Dose-response curve of 20 HCC patient-derived organoids treated with sorafenib. Data are presented as the percentage of control DMSO-treated tumor organoids. (N) IC 50 of indisulam- and sorafenib-treated HCC patient-derived organoids. n = 20. (O and P) Rbm39 and Asns mRNA levels in embryonic day 14 (E14), E18, and adult mouse liver as reads per kilobase of exon per million reads mapped (RPKM). Data from NBCI Gene. n.s. = not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by paired t test (A–C, J, K, and N), multiple t test (F and I), and log rank test (G and H). " width="100%" height="100%">

    Journal: Cell

    Article Title: Arginine reprograms metabolism in liver cancer via RBM39

    doi: 10.1016/j.cell.2023.09.011

    Figure Lengend Snippet: ARG1 and AGMAT are decreased and arginine, RBM39, and ASNS are increased in HCC patient tumors that are sensitive to RBM39 depletion by indisulam, related to Figure 7 (A) RBM39 mRNA levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio. n = 73 (Edm. low), n = 49 (Edm. high). (B) RBM39 protein levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio. n = 30 (Edm. low), n = 21 (Edm. high). (C) ASNS mRNA levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio. n = 73 (Edm. low), n = 49 (Edm. high). (D) ASNS protein levels in liver tumor tissue (T) from HCC patients compared to adjacent non-tumor tissue (NT), displayed as log 2 ratio, if applicable. BW, black-and-white, i.e., only detected in tumor tissues. n = 3 (Edm. low), n = 8 (Edm. high). (E) Staging of ARG1 and AGMAT IHC staining in tissue micro array. (F) mRNA expression of ARG1 , AGMAT , RBM39 , and ASNS in early-stage HCC (data from Jiang et al. ). log 2 fold-change tumor (T) relative to non-tumor (NT) tissues. n = 35. (G) Kaplan-Meier survival estimate curve for TCGA-LIHC patients ranked by expression of ARG1 . n = 135 (low), n =155 (normal). (H) Kaplan-Meier survival estimate curve for TCGA-LIHC patients ranked by expression of AGMAT . n = 136 (low), n = 158 (normal). (I) Polyamine species in tumors (T) relative to paired non-tumor (NT) liver tissues (log 2 ratio). n = 11. (J) Arginine content in paired non-tumor (NT) and tumor (T) tissues of HCC patients. n = 10. (K) Total polyamine content in paired non-tumor (NT) and tumor (T) tissues of HCC patients. n = 10. (L) Volcano plot of the −log 10 (adjusted p value) against the log 2 fold-change of 600 proteins identified by MS (in minimum 2 out of 3 samples) after purification from HCC tissues by arginine (Arg)- compared to leucine (Leu)-coupled agarose beads. Red dot highlights RBM39. (M) Dose-response curve of 20 HCC patient-derived organoids treated with sorafenib. Data are presented as the percentage of control DMSO-treated tumor organoids. (N) IC 50 of indisulam- and sorafenib-treated HCC patient-derived organoids. n = 20. (O and P) Rbm39 and Asns mRNA levels in embryonic day 14 (E14), E18, and adult mouse liver as reads per kilobase of exon per million reads mapped (RPKM). Data from NBCI Gene. n.s. = not significant, ∗ p < 0.05, ∗∗ p < 0.01, ∗∗∗ p < 0.001, ∗∗∗∗ p < 0.0001 by paired t test (A–C, J, K, and N), multiple t test (F and I), and log rank test (G and H).

    Article Snippet: Rabbit anti-AGMAT (for IHC) , Sigma , Cat#PA5-55311.

    Techniques: Immunohistochemistry, Microarray, Expressing, Purification, Derivative Assay

    Journal: Cell

    Article Title: Arginine reprograms metabolism in liver cancer via RBM39

    doi: 10.1016/j.cell.2023.09.011

    Figure Lengend Snippet:

    Article Snippet: Rabbit anti-AGMAT (for IHC) , Sigma , Cat#PA5-55311.

    Techniques: Recombinant, Enzyme-linked Immunosorbent Assay, Luciferase, Reporter Assay, RNA Sequencing Assay, Mutagenesis, CRISPR, Plasmid Preparation, shRNA, Software

    Endometrial expression of mRNAs for progestamedins, enzymes involved in polyamine synthesis, and nutrient transporters. Expression of FGF10 ( d ), AZIN2 (H), SLC6A9 ( q ), and SLC1A4 ( r ) were affected by treatment. Expression of SLC2A1 ( n ), SLC5A1 ( o ), and SLC7A1 ( p ) were affected by day. Expression of FGF10 ( b ), ODC1 ( e ), SLC2A1 ( i ), SLC5A1 ( j ), SLC7A1 ( k ), and SLC6A9 ( l ) were affected by a day × treatment interaction. Expression of FGF7 ( a ), HGF ( c ), AZIN2 ( f ) , and AGMAT ( g ) were not affected by a day × treatment interaction. There was a tendency for the endometrial expression of SLC1A4 ( m ) to be affected by a day × treatment interaction. Data are presented as LSM ± SEM. Different means are indicated by different letters. Only endometria from ewes which were considered pregnant with normally developed conceptuse were utilized for these analyses

    Journal: Journal of Animal Science and Biotechnology

    Article Title: Pre-implantation exogenous progesterone and pregnancy in sheep: I. polyamines, nutrient transport, and progestamedins

    doi: 10.1186/s40104-021-00554-6

    Figure Lengend Snippet: Endometrial expression of mRNAs for progestamedins, enzymes involved in polyamine synthesis, and nutrient transporters. Expression of FGF10 ( d ), AZIN2 (H), SLC6A9 ( q ), and SLC1A4 ( r ) were affected by treatment. Expression of SLC2A1 ( n ), SLC5A1 ( o ), and SLC7A1 ( p ) were affected by day. Expression of FGF10 ( b ), ODC1 ( e ), SLC2A1 ( i ), SLC5A1 ( j ), SLC7A1 ( k ), and SLC6A9 ( l ) were affected by a day × treatment interaction. Expression of FGF7 ( a ), HGF ( c ), AZIN2 ( f ) , and AGMAT ( g ) were not affected by a day × treatment interaction. There was a tendency for the endometrial expression of SLC1A4 ( m ) to be affected by a day × treatment interaction. Data are presented as LSM ± SEM. Different means are indicated by different letters. Only endometria from ewes which were considered pregnant with normally developed conceptuse were utilized for these analyses

    Article Snippet: AGMAT protein was detected using a primary rabbit polyclonal antibody to AGMAT (Abcam 231,894; Cambridge, UK) at a final dilution of 1:250.

    Techniques: Expressing

    Localization of endometrial AGMAT. AGMAT proteins localized to uterine luminal epithelia (LE), superficial glandular epithelia (sGE), GE, and stromal cells in both P4- and CO-treated ewes on day 9 and 12 of pregnancy ( a ). Intensity of AGMAT staining in the GE was decreased in endometria at day 12 compared to day 9 ( P < 0.01) ( b ). A day × treatment interaction for the intensity of AGMAT staining in the LE was observed ( P < 0.001), with increased intensity of AGMAT staining observed in the LE from P4-treated ewes compared to CO-treated ewes at day 12. Scale bar represents 100 μm. Only endometria from ewes which were considered pregnant with normally developed conceptuses were utilized for these analyses

    Journal: Journal of Animal Science and Biotechnology

    Article Title: Pre-implantation exogenous progesterone and pregnancy in sheep: I. polyamines, nutrient transport, and progestamedins

    doi: 10.1186/s40104-021-00554-6

    Figure Lengend Snippet: Localization of endometrial AGMAT. AGMAT proteins localized to uterine luminal epithelia (LE), superficial glandular epithelia (sGE), GE, and stromal cells in both P4- and CO-treated ewes on day 9 and 12 of pregnancy ( a ). Intensity of AGMAT staining in the GE was decreased in endometria at day 12 compared to day 9 ( P < 0.01) ( b ). A day × treatment interaction for the intensity of AGMAT staining in the LE was observed ( P < 0.001), with increased intensity of AGMAT staining observed in the LE from P4-treated ewes compared to CO-treated ewes at day 12. Scale bar represents 100 μm. Only endometria from ewes which were considered pregnant with normally developed conceptuses were utilized for these analyses

    Article Snippet: AGMAT protein was detected using a primary rabbit polyclonal antibody to AGMAT (Abcam 231,894; Cambridge, UK) at a final dilution of 1:250.

    Techniques: Staining